Identifying risk for status epilepticus with the ADAN scale: a prospective multicenter validation studyEMERGENCIASIF6.32024-04-160OA
Exploratory study of blood biomarkers in patients with post-stroke epilepsyEUROPEAN STROKE JOURNALIF4.52024-04-012OA
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosisEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62022-04-0120OAAI
Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?JOURNAL OF MEDICAL GENETICSIF3.72022-02-0410PRE
Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component重新审视英国NF2的遗传严重程度评分: 增加功能性遗传成分的建议JOURNAL OF MEDICAL GENETICSIF3.72021-08-048OA
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in ChildhoodJAMA DERMATOLOGYIF112018-03-0114OAAI
Incidental neuronal intermediate filament inclusion pathology: unexpected biopsy findings in a 37-year-old woman with epilepsyNEUROPATHOLOGY AND APPLIED NEUROBIOLOGYIF3.42017-11-090PREAI
Hypoglycemic seizures and epilepsy in type I diabetes mellitusJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22014-11-0111PREAI
Review of Therapeutic Options for Adjuvant Treatment of Focal Seizures in Epilepsy Focus on LacosamideCNS DRUGSIF7.42011-12-018PREAI